Kenzo Ishihara

Possible involvement of cholinergic nicotinic receptor in insulin release from isolated rat islets

Insulin release is influenced by the autonomic nervous system. Regarding parasympathetic control, previous reports have shown that regulation of insulin release is executed exclusively through muscarinic receptors in the pancreatic islets. In the present study, however, we examined the effect on insulin release at the islet level of various agents affecting the parasympathetic nervous system, especially nicotinic receptor blockers. Pancreatic islets isolated from adult Wistar male rats were incubated with these agents and insulin release in the media was measured. Acetylcholine chloride (10(-5) M), as well as distigmine bromide (10(-6), 10(-5) M), both of which are cholinesterase inhibitors, stimulated insulin release, whereas atropine (5 x 10(-6), 5 x 10(-5) M) suppressed it. On the other hand, serum and IgG from myasthenia gravis patients, containing anti-acetylcholine receptor antibodies, affected insulin release, and alpha-bungarotoxin (10(-9)-10(-7) M), a nicotinic receptor blocker, stimulated insulin release dose-dependently. The present observations suggest that insulin release is influenced by the parasympathetic nervous system, mediated via not only muscarinic but also nicotinic receptors.

Sophisticated mesh filtration technique of a large-scale isolation of islets and their function

A large-scale isolation of islets is required for islet transplantation. We improved our conventional method, and could obtain about three times more islets than by the conventional methods. Pancreata of adult Wistar rats were inflated by injection of buffer with (A) or without 1.3 mg/ml collagenase (B). The rats were bled from the inferior vena cava and the aorta in (A) simultaneously with the inflation. They were further digested with collagenase and filtered through two different meshes (pore size: 1190 and 590 microns) (A1) or three different meshes (pore size: 1190, 590 120 microns) (A2) in order. Insulin released from islets isolated in this manner was determined by 1-h incubation with 3.3 and 16.7 mM glucose. Besides, 600 islets each were transplanted into the liver of streptozotocin-induced diabetic Wistar rats and their fasting plasma glucose was measured at weekly intervals. (1) With these methods more numerous islets were harvested by A1 (mean: 554) and A2 (mean: 746) than B (mean: 224). (2) Insulin released at both glucose concentrations was similar among islets obtained by A1, A2 and B. (3) The plasma glucose-lowering effect was similar among the islets obtained by these methods. (4) A more selected range of islet sizes was obtained by A2 than A1. These observations indicate that the present techniques (A1 and A2) are less time-consuming and simpler for a large-scale isolation of islets.

Effects of tris(hydroxymethyl)aminomethane on biosynthesis and release of insulin in the pancreatic Langerhans islets

Tris(hydroxymethyl)aminomethane (Tris) has been shown to inhibit selectively the Golgi apparatus and Golgi-endoplasmic reticulum-lysosomal system (GERL system) of several kinds of cells including pancreatic B cells. This study was designed to assess the effect of Tris on insulin, glucagon and somatostatin release and insulin synthesis in pancreatic B cells by using isolated rat pancreatic islets. Tris suppressed glucose-induced insulin release, whereas it did not affect the glucagon and somatostatin release. Furthermore, the incorporation of [3H]leucine into the insulin fraction was suppressed by 10 mM Tris, but the sum of the radioactivity of both proinsulin and insulin fraction were not influenced. The present study suggests that the Golgi apparatus and GERL system may play a role in insulin secretion and biosynthesis in pancreatic B cells.

Vacor inhibits insulin release from islets in vitro

It has been reported that Vacor, a rodenticide containing N-3-pyridylmethyl-N’-p-nitrophenyl urea, causes insulin-dependent diabetes mellitus. The pathomechanism of Vacor-induced diabetes mellitus has not been clarified yet. The effect of Vacor, therefore, was studied in terms of insulin release from isolated rat pancreatic islets. Vacor suppressed glucose-stimulated insulin release, but did not affect the insulin release induced by theophylline or 12-o-tetra-decanoylphorbol 13-acetate. It is suspected that the suppression of insulin release from pancreatic islets by Vacor may contribute to the pathogenesis of Vacor-induced diabetes mellitus and that this suppression might not be related to cAMP and C-kinase.

Effect of cooling rate on insulin release from frozen-thawed dispersed rat islet cells

Rat islet cells, dissociated with EDTA-Dispase, were immersed in 10% dimethyl sulfoxide at 20 degrees C for 15 min and frozen to -40 degrees C at a cooling rate of 0.5 or 1.0 degree C/min and subsequently further to -80 degrees C at 3 degrees C/min by a programmable freezer. After being maintained at -80 degrees C for 10 min, they were rapidly thawed in a water bath at 37 degrees C. They were cultured for 12 h and preincubated in 3.3 mM glucose-containing Krebs-Henseleit bicarbonate buffer (KHBB) for 1 h. Groups of 10(4) cells were then incubated in 3.3 or 16.7 mM glucose-containing KHBB for another hour. As a control, non-frozen-thawed cultured islet cells were incubated similarly. The non-frozen rat islet cells released 1.29 pg insulin/cell.60 min in the presence of 3.3 mM glucose and this release level was significantly elevated to 1.64 pg insulin/cell.60 min in the presence of 16.7 mM glucose. The cells frozen at 0.5 degree C/min releasing 1.55 pg insulin/cell.60 min in the presence of 3.3 mM glucose also responded to 16.7 mM glucose and released the significantly high level of 1.87 pg insulin/cell.60 min. However, the islet cells frozen at a cooling rate of 1 degree C/min secreted 1.74 and 1.92 pg insulin/cell.60 min in the presence of 3.3 mM and 16.7 mM glucose respectively. There was no significant difference between these levels. These results indicate that cryopreservation at a cooling rate of 0.5 degree C/min may be adequate for the preservation of dispersed pancreatic endocrine cells.

Production of anti-insulin monoclonal antibody and its application to immunoassay of insulin and immunohistochemistry

An unlimited supply of suitable antisera is wanted for immunoassays, analysis of antigenic determinants and precise localization of antigens in biological systems. Therefore, we produced a monoclonal antiporcine insulin antibody by the hybridoma technology and assessed it in comparison with polyclonal antibody. The spleen cells of BALB/c mice immunized against porcine insulin were hybridized with mouse myeloma cells (P3-X63-Ag8-U1). The monoclonal antibody thus generated was shown to have high binding capacity and specificity to porcine insulin in radioimmunoassay. It reacted with human insulin as well, but did not crossreact with other polypeptide hormones produced in the pancreatic islets such as glucagon, somatostatin and pancreatic polypeptide. In immunohistochemistry human and dog islets were stained by this monoclonal antibody. Rat islets were not stained, although they reacted with polyclonal anti-insulin antibody. The insulin of human serum samples measured using the monoclonal antibody was tightly correlated with that using the polyclonal antibody. These observations indicate that our hybridoma-derived monoclonal antibody is useful for immunoassay as well as localization of insulin.

Evaluation of cryopreservation techniques of pancreatic fragments and islets in vitro and in vivo

We evaluated cryopreservation techniques for pancreatic fragments and islets using rat tissue. After equilibration in 10% dimethyl sulfoxide (Me2SO), the tissue was frozen in a programmable freezer at 1 degree C/min down to -40 degrees C and at 3 degrees C/min down to -71 degrees C. The islets, when thawed, released abundant insulin in the presence of as little as 3.3 mM glucose, much more so than non-frozen islets did. Three additional procedures, prefreezing and post-thawing culture and the stepwise dilution of the Me2SO, lowered the non-specific insulin release of the thawed islets and improved their insulin response to 16.7 mM glucose. Thawed pancreatic fragments subjected to these additional procedures, transplanted into the peritoneal cavity of streptozotocin-induced diabetic rats, reduced their hyperglycemia significantly. The thawed fragments and islets did not differ from their corresponding non-frozen controls in 3H-leucine incorporation. The maintenance of tissue function was not satisfactory. However, our observations indicate that culturing pancreatic tissue before freezing and after thawing and the stepwise dilution of the cryoprotective agent reduce the damage induced by freezing the tissue.

Production of anti-insulin monoclonal antibody and its clinical application

Hybridoma-produced monoclonal antibody (MoAb) against insulin is useful for insulin assays because of its specificity and plentiful supply. The spleen cells of male BALB/c mice immunized against monocomponent porcine insulin were hybridized with mouse myeloma cells (P3-X63-Ag8-U1). The resulting anti-insulin antibody (Ab) was purified and characterized by radioimmunoassay (RIA) using 125I-porcine insulin and sandwich-method enzyme immunoassay (EIA) using Ab-conjugated beads and beta-galactosidase. For reference, we used anti-insulin polyclonal antibody raised in guinea pigs (PoAb). Using the Ouchterlony technique, we identified the antibody as being of subclass IgG 1. We judged this antibody to be MoAb because it did not react at all with porcine insulin during EIA, in concentrations between 0 and 12.5 ng/ml; in contrast, PoAb reacted dose-dependently. During RIA, this Ab did not cross-react with glucagon, somatostatin or pancreatic polypeptide. It did cross-react with human and bovine insulins but not with rat insulin. The proper concentration of this MoAb for RIA proved to be 1:1,500,000 and the smallest detectable level of porcine insulin by RIA using this Ab was 0.5 ng/ml. These levels were similar to those obtained with PoAb. The binding activity of this MoAb to human insulin was quite similar to that of porcine insulin. RIA insulin determinations using our MoAb correlated well with those employing PoAb.

Islet function after storage at −2°C and −196°C

Abstract The radical treatment of type 1 diabetes by transplantation requires the extracorporeal storage of islets, and this has frequently been studied. Damage from ice formation, however, has prevented the development of any satisfactory method for preservation. We compared islet function after frozen storage with that after non-frozen storage. Isolated rat islets immersed in 10% dimethyl sulfoxide were kept at −2°C (group A) and −196°C (group B) for 7 days. After one day of culture, some of the islets were incubated in 3.3 and 16.7 mM glucose-containing Krebs-Henseleit bicarbonate buffer for 60 min. The other islets were incubated with 3 H-leucine for 2 h. The radioactivity of whole-islet homogenate and the insulin extracted from it were measured. We also counted the number of islets before and after the 7-day storage. The islets thus preserved were transplanted into streptozotocin-induced diabetic rats and the fasting plasma glucose was determined weekly. Non-cooled islets were used as controls (group C). Insulin release in the presence of 16.7 mM glucose did not significantly differ between groups C and A, whereas it was lower in group B than in groups A or C. The islet uptake of 3 H-leucine was lower in A and B compared with C, but the insulin synthesis was similar in all three groups. More islets were recovered from A than B. Fasting plasma glucose was lowered similarly in the diabetic rats after transplantation of islets from A and B. The relative ease of preservation at −2°C, and the positive results of this experiment, favor this method of preservation.

Effect of the cooling rate on insulin release from frozen-thawed In-111 cells

Cultured cells derived from hamster insulinoma (In-111 R1 cells) were placed in 1.4 M dimethyl sulfoxide (Me2SO)-containing RPMI 1640 at 20 degrees C for 20 min. They were frozen to -40 degrees C at a cooling rate of 1.0 or 0.5 degrees C/min, subsequently to -80 degrees C at 3 degrees C/min with a programmable freezer. After being maintained at -80 degrees C, they were rapidly thawed to 37 degrees C. Thawed cells were washed with 0.75 M sucrose for removal of Me2SO. Recovered cells were cultured in 2 ml of RPMI 1640 with 1.3 mM theophylline under a gas phase of 95% air -5% CO2 at 37 degrees C for 2 days. In both cooling rates, frozen-thawed cells discharged more insulin than the thawed in the absence of theophylline. However, this released insulin level was higher in the cells frozen at a cooling rate of 0.5 degrees C/min than that at 1.0 degrees C/min. Moreover, insulin released from frozen-thawed hamster insulinoma cells increased significantly with the addition of 1.3 mM theophylline. Considering that the higher insulin release level at 11.1 mM glucose alone might indicate cellular damage, it is suggested that the cooling rate of 1 degree C/min may be better for cryopreservation of the dispersed cells under the present protocol for the assessment of the function of insulin release.